6-Hydroxydopamine promotes antitumor immunity through macrophage remodeling beyond sympathetic ablation
Neuron · 2026
DOI: 10.1016/j.neuron.2026.02.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2026. Verfasst von Jialin Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Beijing Institute for Brain Research…. Hauptthemen laut MEDLINE: Oxidopamine, Macrophages, Sympathetic Nervous System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Beijing Nova Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
The sympathetic nervous system has emerged as a critical regulator of cancer progression, yet the underlying mechanisms remain unclear. Here, we compare genetic, pharmacological (6-hydroxydopamine [6-OHDA]), and surgical denervation in mouse breast cancer models. While all methods deplete sympathetic nerves, only 6-OHDA suppresses tumor growth, revealing a disconnect between sympathetic ablation and antitumor effect. Mechanistic investigations reveal that 6-OHDA suppresses tumor growth through immune activation rather than sympathetic ablation. 6-OHDA induces cancer cell interferon (IFN)-β production, which promotes monocyte differentiation into pro-inflammatory macrophages characterized by interferon-stimulated gene (ISG) expression. These ISG+ macrophages are essential for the expansion of type 1 T helper (TH1) cells, which mediate prolonged tumor suppression. By contrast, sympathetic ablation alone does not affect macrophage differentiation or tumor growth. Our findings uncover an immunomodulatory function of 6-OHDA beyond its established neurotoxic activity and suggest the therapeutic potential of harnessing the macrophage-TH1 axis for breast cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China; Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College,…
- Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing 102206, China; Academy for Advanced Interdis…
- Department of Molecular Biology and Biochemistry, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100005, China.
- Beijing Institute for Brain Research, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 102206, China; Chinese Institute for Brain Research, Beijing 102206, China.
Förderung
- Beijing Nova Program
- National Natural Science Foundation of China
Zitieren
APA
Yu, J., Zhang, H., Li, M., Chen, S., & Shi, W. (2026). 6-Hydroxydopamine promotes antitumor immunity through macrophage remodeling beyond sympathetic ablation. Neuron. https://doi.org/10.1016/j.neuron.2026.02.028
Vancouver
Yu J, Zhang H, Li M, Chen S, Shi W. 6-Hydroxydopamine promotes antitumor immunity through macrophage remodeling beyond sympathetic ablation. Neuron. 2026. doi:10.1016/j.neuron.2026.02.028
BibTeX
@article{Yu2026,
author = {Yu, Jialin and Zhang, Hao and Li, Meiyao and Chen, Shanshan and Shi, Wei},
title = {6-Hydroxydopamine promotes antitumor immunity through macrophage remodeling beyond sympathetic ablation},
journal = {Neuron},
year = {2026},
doi = {10.1016/j.neuron.2026.02.028}
}
EUVIMED